Back to top

Is This the Top for Symmetry Medical Inc. (SMA)?

Read MoreHide Full Article
Although Symmetry Medical Inc. (SMA) is up over 19.2% in the past four weeks, investors may be concerned. After all, SMA is now in overbought territory, at least when looking at its RSI value of 75.1. If that wasn’t enough, investors should also note that Symmetry Medical Inc. possesses a Zacks Rank 4(Sell), so if analyst perception is any guide, we could witness a slump in SMA shares before too long.

Normally $25 each - click below to receive one report FREE:

More from Zacks Tale of the Tape

You May Like